One North Texas sweet shop owner said his average customer is not concerned about whether their donut is made with an oil containing trans fat or one that is trans fat-free, but the FDA cares and made a first time ruling concerning trans fats.
The Supreme Court will not review an Oklahoma court ruling that struck down a state law limiting drug-induced abortions.
The Food and Drug Administration is recommending new restrictions on prescription medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.
A new high-dose flu vaccine for seniors works better than the standard shot in that age group. Regular flu shots tend to be only about 30 to 40 percent effective in people 65 and older. Sanofi Pasteur’s Fluzone High-Dose vaccine boosted that to 50 percent.
New research suggests that high levels of BPA, a chemical in many plastics and canned food linings, might raise the risk of miscarriage in women prone to that problem or having trouble getting pregnant.
Garden Fresh Foods of Milwaukee has recalled 19,000 pounds of ready-to-eat chicken and ham products because of possible Listeria bacteria contamination.
Dallas County Health and Human Services announced that it has a limited amount of the Adult Safety Net Program meningitis vaccine for $10.
The results of a long-term major federal study that was done in Texas is easing worries about the safety of a hormone-blocking drug that can lower a man’s chances of developing prostate cancer.
A woman claiming she was infected by cyclospora, a rare type of parasite that causes symptoms such as diarrhea, weight loss and nausea, is taking legal action.
Consumers are going to know exactly what they’re getting when they buy foods labeled “gluten free.” The Food and Drug Administration is defining what the “gluten free” label really means.
Whole Foods Market is recalling a brand of cheese due to a possible risk of Listeria contamination.
Hair loss is one of chemotherapy’s most noticeable and despised side effects. Now U.S. researchers are about to put an experimental hair-preserving treatment to a rigorous test.